Clinical Trial Update: Ropivacaine Transversus Abdominis Plane Blocks for Cesarean Section Analgesia [NA]

View source ↗

Summary

This clinical trial update reports termination of a study evaluating ropivacaine TAP blocks for cesarean section analgesia with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Pain

Drugs mentioned

• Ropivacaine (Ropivacaine)

Snippet

Sponsor: Maimonides Medical Center | Conditions: Postoperative Pain | NA | Status: TERMINATED | Results posted: 2022-09-21